200
Participants
Start Date
July 7, 2022
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
CpG-adjuvanted HBV Vaccine
Subjects receiving CpG-adjuvanted HBV vaccine will require two doses at 0 and 1 month after initiation. The second dose will be considered the same as the one month time point following the first dose.
Traditional HBV Vaccine
Subjects receiving traditional HBV vaccine series will require three doses at 0, 1, and 6 months after initiation. The second dose will be considered the same as the one month time point following the first dose.
RECRUITING
NYU Langone Health, New York
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NYU Langone Health
OTHER